drugmaker

Sandoz Builds Biologics Plant in Slovenia

Sandoz, the generics and biosimilars arm of Swiss drugmaker Novartis, has signed a Memorandum of Understanding to build a biologics production plant in Lendava, Slovenia.

Novo Nordisk to Cut US Insulin prices from 2024

Danish drugmaker Novo Nordisk has added its name to the list of insulin producers cutting prices for US retail buyers, following up on Eli Lilly’s announcement of price cuts and in response to growing pressure from the White House.

Sanofi Strengthens Venture Capital Budget

As well as serving as a financial partner to fledgling companies, the VC fund supports future efforts for business development and M&A opportunities within its own operations, Sanofi said. The fresh capital injection will also fuel the expansion and investment capacity of its own investment team on a global scale.

Bayer Shifting Pharma Focus away from Europe

Bayer is increasingly shifting the commercial focus of its pharmaceutical business away from Europe and toward the US and China, Stefan Oelrich, head of the German group’s pharmaceuticals arm, said in an interview with Financial Times during the JPMorgan Healthcare conference in San Francisco.

US Opioid Settlement Talks in High Gear

Pershing and Valeant Settle Allergan Lawsuits

GSK Expands Stake in Saudi Subsidiary

Teva Takes Back a few Job Cuts

Novartis to Close US Generics Unit, Keep Roche Stake

Novo Nordisk Settles $58.7 Million in US Fines

Mylan Finalizes US EpiPen Settlement

Teva Cuts Jobs, Closes Plants as Woes Deepen

Activist Investor Ackman Exits Valeant

Teva Facing Bribery Charges in Israel

Teva CEO Erez Vigodman Steps Down

Novo Nordisk Invests in UK Research Center

Valeant $2 Billion Assets Sale Will Pare Debt

Takeda to Take Ariad for $5.2 Billion

Ebola Vaccine Trials Prove Efficacy

Boehringer in China R&D Pact, Job Cut Plans

GSK Sued by Former Private Investigators

Valeant Selling Salix to Takeda?

GSK’s Witty for Responsible Pricing

Supervisory Chief Ousted at Stada

Valeant Names New Finance Chief

Simone Menne Named CFO of Boehringer Ingelheim

Sanofi Moves to Replace Medivation's Board

Sanofi Takes Case for Medivation to the SEC

AstraZeneca Initiates Broad Genomics Project

Ackman Trims Valeant Stake to Create Tax Benefits

Sanofi Launches new Long-term Strategy

Court Says Mylan Can Uphold Perrigo Bid

M&A Carousel Turns Faster as Deals Set New Records

Actavis Begins Trading as Allergan

Perrigo Buying GSK, Novartis Consumer Brands